Cyclo Therapeutics, Inc.

The current price of CYTH is 1.30 USD — it has increased by 7.44% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cyclo Therapeutics, Inc. stocks are traded under the ticker CYTH.

Cyclo Therapeutics, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

CYTH stock is 8.20% volatile and has beta coefficient of 2.45. Check out the list of the most volatile stocks — is Cyclo Therapeutics, Inc. there?

CYTH earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.27 USD resulting in a −7.41% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Cyclo Therapeutics, Inc. earnings.

Cyclo Therapeutics, Inc. revenue for the last quarter amounts to ‪495.48 K‬ USD despite the estimated figure of ‪141.00 K‬ USD. In the next quarter revenue is expected to reach ‪169.00 K‬ USD.

Yes, you can track Cyclo Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

CYTH stock has risen by 10.17% compared to the previous week, the month change is a 10.96% fall, over the last year Cyclo Therapeutics, Inc. has showed a 55.95% increase.

Today Cyclo Therapeutics, Inc. has the market capitalization of ‪34.75 M‬, it has increased by 3.28% over the last week.

No, CYTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CYTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cyclo Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

CYTH reached its all-time high on Oct 4, 1995 with the price of 400.00 USD, and its all-time low was 0.67 USD and was reached on Apr 5, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 8.00 employees. See our rating of the largest employees — is Cyclo Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cyclo Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cyclo Therapeutics, Inc. stock shows the sell signal. See more of Cyclo Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Cyclo Therapeutics, Inc. future price: according to them, CYTH price has a max estimate of 4.00 USD and a min estimate of 2.60 USD. Read a more detailed Cyclo Therapeutics, Inc. forecast: see what analysts think of Cyclo Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cyclo Therapeutics, Inc. EBITDA is ‪−20.03 M‬ USD, and current EBITDA margin is ‪−1.86 K‬%. See more stats in Cyclo Therapeutics, Inc. financial statements.